Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
12 hedge funds and large institutions have $735K invested in Genetic Technologies Ltd. in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 6 closing their positions.
20% less funds holding
Funds holding: 15 → 12 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
51% less capital invested
Capital invested by funds: $1.49M → $735K (-$753K)
58% less call options, than puts
Call options by funds: $278K | Put options by funds: $661K
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$59K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$46.7K |
| 3 |
VF
Virtu Financial
New York
|
+$45.8K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$10.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$154K |
| 2 |
Morgan Stanley
New York
|
-$108K |
| 3 |
Jane Street
New York
|
-$74K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$64K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$58.7K |
GENE Hedge Fund Activity: Q3 2021 in Review
12 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q3 2021, worth a combined $735K — down 51% from $1.49M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of GENE and 3 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 1 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $59K. The largest seller was Susquehanna Fundamental Investments, exiting entirely with an estimated $154K sold.
- 12 institutional investors held Genetic Technologies Ltd. (GENE) as of Q3 2021, down from 15 in Q2 2021.
- Funds reported $735K of Genetic Technologies Ltd. stock for Q3 2021, down 51% quarter-over-quarter.
- 3 funds opened new Genetic Technologies Ltd. positions in Q3 2021 and 6 closed out, a net change of -3 holders.
- The largest Genetic Technologies Ltd. buyer in Q3 2021 was Millennium Management, an estimated $59K added.
- The largest Genetic Technologies Ltd. seller in Q3 2021 was Susquehanna Fundamental Investments, an estimated $154K sold.
Based on aggregated 13F filings for Q3 2021.